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CBP/p300 coactivatorein of human T-cell leukemia virus type 1 (HTLV-1) as an interferon (IFN)-α
antagonist counteracting the transactivation function of IFN-stimulated gene factor 3 (ISGF3). Co-expression
of Tax, but not the Tax mutant unable to bind to CBP, signiﬁcantly inhibited the reporter gene expression
directed by IFN-stimulated regulatory elements, despite that the formation of DNA-binding ISGF3 complex
was unaffected. Gene activation induced by STAT2 transcription domain was also inhibited by expression of
Tax. Furthermore, Tax-mediated transcriptional inhibition was reversed by overexpression of p300. These
observations indicate that Tax interferes with IFN-α-induced JAK-STAT pathway by competition with STAT2
for CBP/p300 binding. Consistently, GST pull-down assay showed that Tax dose-dependently inhibited
binding of STAT2 to p300. This study suggests that Tax may prevent IFN-α from exerting its antiviral,
antiproliferative and proapoptotic effects, thereby contributing to persistent viral infection and HTLV-1-
associated oncogenesis.
© 2008 Elsevier Inc. All rights reserved.Introduction
Human T-cell leukemia virus type 1 (HTLV-1) is an oncogenic
retrovirus responsible for development of adult T-cell leukemia/
lymphoma (ATLL) (Yoshida et al., 1984) and HTLV-1-associated
neurodegenerative diseases such as myelopathy/tropical spastic
paraparesis (HAM-TSP) (Gessain et al., 1985; Osame et al., 1986).
ATLL is highly chemoresistant and its prognosis is usually poor. After
conventional chemotherapy failure, interferon (IFN)-α combinedwith
antiretroviral reagents such as zidovudine produces clinical remission
followed by progression and death (Gill et al., 1995; Hermine et al.,
1995). HTLV-1-associated oncogenesis has been demonstrated to be
largely attributable to the expression of the viral regulatory protein
Tax (Grassmann et al., 1989; Grassmann et al., 1992). In addition to its
role in activating proviral transcription, Tax has been shown to
activate transcription through protein–protein interactions with
multiple transcription factors including the cyclic AMP-responsive
element-binding factor (CREB), NF-κB, and the serum-responsive
element-binding factor (SRF). Tax stimulates viral transcription
through interacting with three conserved 21-bp repeat DNA elements
known as viral CREs located within the HTLV-1 promoter. Tax binds to.
l rights reserved.the CRE sequences in complex with the transcriptional factor CREB,
which subsequently facilitates the transcription by recruitment of the
cellular coactivators CBP (CREB-binding protein) and p300 (Giebler et
al., 1997; Kwok et al., 1996).
CBP and p300 were originally identiﬁed as targets of CREB and
adenovirus E1A, respectively (Chrivia et al., 1993; Eckner et al., 1994).
They are large nuclear phosphoproteins that act as global transcrip-
tional coactivators by binding numerous transcription factors (Jan-
knecht and Hunter, 1996). CBP/p300 functions as coactivator or
adapter by bridging transcription factors to general transcription
machinery such as TFIIB, TBP and RNA polymerase II. In addition, CBP/
p300 might contribute to transcriptional regulation by acetylation of
chromatin via its intrinsic histone acetyltransferase (HAT) activity or
its association with another HAT, p/CAF (Bannister and Kouzarides,
1996; Ogryzko et al., 1996; Yang et al., 1996). The simultaneous
interaction of multiple transcription factors with CBP/p300 has been
proposed to contribute to transcriptional synergy. Conversely, com-
petition for limiting amounts of CBP/p300 has been suggested as a
potential mechanism for transcriptional repression.
IFNs are a family of immunomodulatory cytokines that are
produced in response to virus infection and possess both antiviral
and antiproliferative functions. Secreted IFNs act in an autocrine or
paracrine fashion to activate JAK-STAT pathway by binding to IFN
receptors (IFN-α/β to IFNAR1/IFNAR2 and IFN-γ to IFNGR1/IFNGR2).
Fig.1. Effect of Tax or its mutants on IFN-α-induced ISRE signaling. Huh-7 (A) or Jurkat T
cells (C) were transfected with ISRE-luc together with pCn, pCnwtax, pCnm148, or
pCnm319. Cells were either left untreated or treated with 100 IU/ml of human IFN-α
24 h later, and the luciferase activity was measured following a further incubation for
24 h. Renilla luciferase activities from cotransfected pRL-TK were used to normalize the
transfection efﬁciency. Normalized luciferase activity from an otherwise identical
control transfection with pCn backbone vector was set as 100%, and those in other
transfectants are expressed as relative percentage. Results are presented as the means
and standard deviations of four independent triplicate transfections. (B) Expression of
Tax protein in each transfectant was conﬁrmed by Western blot analysis. Solid arrow
indicates the signals of Tax protein.
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heterodimers, with other STAT proteins, which subsequently translo-
cate to nucleus and bind speciﬁc DNA sequences within the promoter
region of IFN-stimulated genes (ISGs). In the case of signaling via IFN-
α/β, heterodimer of phosphorylated STAT1 and STAT2 interacts with
IFN regulatory factor 9 (IRF9; p48) to form the trimer transcription
complex ISGF3 (IFN-stimulated gene factor 3). By recruiting the
transcriptional coactivator CBP/p300, ISGF3 triggers the expression of
a variety of genes driven by the promoter containing IFN stimulated
response elements (ISRE). Viruses have evolved different strategies to
subvert IFN response, mainly by interfering IFN induction, perturbing
IFN signaling and inhibiting IFN-induced effectors. Viral proteins
acting as IFN antagonists have been identiﬁed in a numbers of viruses
belonging to different families. Additionally, employing its antiproli-
ferative and proapoptotic properties, IFN has been used as a
therapeutic agent for multiple hematological and non-hematological
malignancies. The anti-tumor efﬁcacy, however, is limited by
emergence of IFN resistance, a phenomenon attributable to the
functional defects involved in IFN signaling pathway (Sun et al., 1998).
Here we present evidence demonstrating that HTLV-1 Tax
interferes with the JAK-STAT signal transduction pathway in response
to IFN-α, and the mechanism underlying the antagonistic function
involves interaction of Tax with coactivator CBP/p300 in competition
with STAT2, thereby inhibiting the transcription activation of STAT2-
containing ISGF3 complex.
Results
Inhibition of IFN-α-induced ISRE signaling by Tax
By analyzing the inﬂuence of Tax protein on replication of hepatitis
C virus (HCV) replicon, we previously showed an attenuated IFN-α-
induced antiviral response in Tax-expressing Huh-7 cells (Zhang et al.,
2007). If Tax inhibits IFN-α response, interference could occur via
global interruption of the JAK-STAT signal transduction pathway or via
inhibition of speciﬁc ISG products such as protein kinase R or 2′,5′-
oligoadenylate synthetase. To deﬁne a possible role of Tax in
modulating IFN-α signaling, Tax- or Tax mutant-expressing plasmid
was transfected into Huh-7 cells together with the reporter vector
pISRE-luc to monitor ISRE-directed gene expression. Cells were either
left untreated or treated with 100 IU/ml of human IFN-α 24 h later,
and the luciferase activity was measured following a further
incubation for 24 h. As shown in Fig. 1A, both the wild type and the
Tax mutant m148, previously demonstrated to be functional in
activating CREB pathway while failing to activate NF-κB pathway,
signiﬁcantly inhibited IFN-α induced ISRE-directed luciferase expres-
sion, while the Tax mutant m319, unable to activate CREB pathway
although retaining the ability to activate NF-κB pathway (Yamaoka et
al., 1996), had no signiﬁcant effect on ISRE-driven gene expression,
indicating that Tax inhibits ISRE-directed gene expression and its
competence for signaling through CREB is important for the observed
inhibition. Western blot analysis showed a comparable expression of
Tax and Tax mutants (Fig. 1B). Similar results were also observed with
Jurkat T cells (Fig. 1C), suggesting that Tax-mediated inhibition of JAK-
STAT signaling in response to IFN-α was not cell-type speciﬁc. These
results suggest that Tax interferes with IFN-α response by a global
transcriptional repression of downstream effector gene expression.
Tax does not affect the formation of DNA-binding ISGF3 complex
As forementioned above, IFN-α signaling through the JAK-STAT
pathway involves a series of events including tyrosine phosphoryla-
tion of STAT1 and STAT2, formation and nuclear translocation of ISGF3
followed by its binding to ISREs. Impairment at any of these steps
might consequently lead to blockade of IFN-α-induced signaling. To
understand the mechanism employed by Tax to counteract IFN'sactions, we next investigated the formation of ISRE-binding ISGF3 in
Huhwtax. Huhwtax is a cell line stably expressing Tax at a level
comparable to HTLV-1-infected MT-2 cells (Fig. 2B), which was
established by transfection with pCnwtax followed by G418 selection
and limiting dilution (Zhang et al., 2007). Nuclear extracts were
prepared and subjected to electrophoretic mobility shift assay (EMSA)
using the labeled ISRE as an oligonucleotide probe. As seen in Fig. 2A,
in IFN-α-treated HuhCn cells, which were stably transfected with the
empty vector pCn and served as a negative control, ISRE–protein
complexes of delayed electrophoretic mobility was detected (lane 2),
which was diminished by addition of antibody against STAT1 or STAT2
(lanes 7–8) but not by irrelevant antibody to β-actin (lane 9),
conﬁrming the identity of the ISRE-binding factor as ISGF3. The
formation of ISRE–protein complex was signiﬁcantly inhibited by
addition an excess of unlabeled ISRE as a competitor (lane 3), revealing
the speciﬁcity of the observed ISRE–protein binding. Unexpectedly,
IFN-α-induced ISGF3 formation in Huhwtax was comparable to that
detected in HuhCn (lanes 4–6). While expression of Tax conferred an
attenuated IFN-α-induced antiviral response in Huhwtax cells (Zhang
et al., 2007), the formation of ISRE-binding ISGF3 complex in their
nuclear extract was not affected, which suggests that Tax inhibits IFN-
Fig. 2. Tax does not affect the formation of ISGF3 complex on ISRE promoter. (A) HuhCn
or Huhwtax cells were treated in the absence or presence of 500 IU/ml of human IFN-α
for 30 min. Nuclear extracts were prepared for EMSA analysis using labeled ISRE probe.
In lanes 3 and 6, 50-fold molar excess of unlabeled ISRE competitor were included. In
lanes 7–9, nuclear extracts were pre-incubated with the antibodies against STAT1,
STAT2 or irrelevant β-actin (anti-IR) for 30 min prior to the addition of labeled probe.
(B) Stable expression of Tax protein in Huhwtax cells was conﬁrmed by Western blot
analysis. Solid arrow indicates the signals of Tax protein.
Fig. 3. Inhibition of STAT2 transactivation function by Tax. GAL4 carries the DNA binding
domain only; GAL4-Stat2(TA) and GAL4-VP16 contain the transactivation domain of
STAT2 and VP16 fused directly with the binding domain of GAL4; GAL4-Stat2(TA)Δ is a
mutant of GAL4-Stat2(TA) with C-terminal 83 amino acids of STAT2 deleted. HeLa cells
were transfected with the indicated expression constructs together with the GAL4-luc
reporter vector, and luciferase activities were determined and calculated as described
for Fig. 1. The results are from four independent triplicate experiments.
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DNA-binding ISGF3 complex.
Tax represses transactivation function of STAT2
The results presented above imply that Tax averts IFN-α function
via a mechanism other than inhibiting the activation and/or nuclear
translocation of ISGF3 components. It is known that the C terminus
of STAT2 serves as a transcriptional activation (TA) domain, which is
essential for ISGF3 function. We next examined whether Tax could
inhibit the transactivation function of STAT2. To this end, we
constructed a vector pGAL4-Stat2(TA) by fusing the GAL4 DNA
binding domain with the C-terminal 181 residues-coding region of
STAT2. Expression of reporter gene from pGAL4-luc vector in HeLa
cells was signiﬁcantly induced by cotransfection with pGAL4-Stat2
(TA), but not by pGAL4-Stat2(TA)Δ with C-terminal 83 amino acids
deleted, conﬁrming the transactivation potential of the C terminus
of STAT2 (Fig. 3). Importantly, cotransfection with Tax-expressing
plasmid markedly inhibited the GAL4-Stat2(TA) transactivation
activity, resulting in an approximately ﬁve- to six-fold lower
luciferase expression when compared with the transfection in the
absence of Tax. In contrast, the activation of the transcription from
pGAL-luc by GAL4-VP16, which contains the activation domain of
VP16 instead of Stat2 in GAL4-Stat2(TA), was not obviously affected
by Tax protein, indicating that Tax-mediated inhibition of STAT2
transactivation is not due to an impairment of the general
transcription machinery in Tax-expressing cells. Additionally, this
result further excluded the possibility that Tax-mediated inhibition
of ISGF3-directed transcription was attributable to the perturbation
of events such as nuclear translocation because both GAL4-Stat2(TA)
and GAL4-VP16 utilizes the same nuclear localization signal of GAL4.
Taken together, these results suggest that Tax protein inhibits IFN-α
signaling via repressing STAT2 transactivation.Tax down-modulates IFN-α signaling by competitive binding to
CBP/p300 coactivator
It has been demonstrated that STAT2 and STAT2-containing ISGF3
function in transcriptional activation partly through recruitment of
CBP/p300 (Bhattacharya et al., 1996). Likewise, Tax also utilizes CBP/
p300 for implementing its transcriptional activation competence, and
moreover, Tax has been shown to inhibit CBP/p300-mediated
transcription by competitive usage of the coactivator. Accordingly, a
possible mechanism for Tax-mediated inhibition of IFN-α-activated
ISGF3 transactivation is through binding to CBP/p300 in competition
with STAT2. If it is true, the binding ability of Tax to CBP/p300 should
be crucial for its repression of ISGF3 transactivation. To test this
hypothesis, we investigated whether the mutant TaxK88A, defective
in CBP/p300 binding, could exert similar repressive effect on ISGF3-
directed transcription. As shown in Fig. 4A, the inhibitory effect of Tax
on IFN-α-stimulated luciferase expression from pISRE-luc was
completely abrogated by the mutation introduced in TaxK88A,
revealing a correlation between CBP/p300-binding and ISGF3 repres-
sion. Similar result was obtained from the reporter assay with pGAL4-
Stat2(TA) and pGAL4-luc, conﬁrming that the binding of Tax to CBP/
p300 is responsible for the inhibition of STAT2 and ISGF3 transactiva-
tion by Tax. Comparable expression of Tax and TaxK88A in each
transfectant was conﬁrmed by Western blot analysis (Fig. 4B).
To further verify the hypothesis that competition for limiting CBP/
p300 is amechanism for theobservedTax-mediated ISGF3 inhibition,we
Fig. 4. Tax's ability to bind to CBP is critical for its repressive effect on STAT2
transactivation. (A) Huh-7 cells were transfected with ISRE-luc (upper) or GAL4-luc
(lower) together with pCn, pCnwtax or pCnTaxK88A.Mutant TaxK88A harbors an amino
acid substitution at condon 88 from lysine to alanine and is defective in CBP/p300
binding. Cells were treated with 100 IU/ml of human IFN-α 24 h later, and the luciferase
activity was measured following a further incubation for 24 h. Renilla luciferase
activities from cotransfected pRL-TK were used to normalize the transfection efﬁciency.
Normalized luciferase activity from an otherwise identical control transfectionwith pCn
vector was set as 100%, and those in other transfectants are expressed as relative
percentage. Representative data are from ﬁve independent triplicate transfections. (B)
Similar level of Tax expression in cells transfected with pCnwtax or pCnTaxK88A. Cells
transfected with each indicated construct were harvested 48 h posttransfection, and
Western blot analysis was performed using anti-Tax antibody (AS-5703). Solid arrow
indicates the signals of Tax protein.
Fig. 5. Tax-mediated inhibition of STAT2 transactivationwas reversed by overexpression
of p300. (A) ISRE-luc reporter vector was transfected into Huh-7 cells together with pCn,
pCnwtax and/or p300. Relative luciferase activities were determined and calculated as
described for Fig. 1. Representative results are from three independent triplicate
transfections. (B) Comparable Tax expression in cells irrespective of p300 co-expression
was conﬁrmed by Western blot analysis.
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restore the reduced ISGF3 transcriptional activity by Tax. In the absence
of Tax, expression of p300 enhanced ISRE-directed luciferase gene
expression in response to IFN-α (Fig. 5A), indicating a rate limiting level
of p300 within the nucleus. Noteworthily, cotransfection of p300
expression plasmid completely restored the Tax-mediated inhibition of
ISGF3 transactivation. Western blot analysis showed a similar Tax
expression in Huh-7 cells irrespective ofwhether p300was expressed or
not (Fig. 5B), excluding thepossibility that derepressionof ISGF3 function
by overexpression of p300 is due to reduced Tax expression in cells
overexpressing p300. Together, these results strongly suggest that Tax-
mediated inhibition of ISGF3 transactivation potential is mediated by
competitive usage of CBP/p300 between Tax and STAT2.Competition between Tax and STAT2 for p300 binding
To provide further evidence supporting the competition model
proposed above, we next determined whether Tax could bind to p300
in competition with STAT2 in vitro. GST pull-down assay was
performed using the GST-p300302–661 fusion protein containing GST
fused to amino acids 302–661 of p300, which encompasses the
homologous region of the CH1 and KIX domains of CBP. Puriﬁed GST-
p300302–661 was bound to glutathione-agarose beads and then
incubated with labeled in vitro translated Tax or STAT2 protein.
Puriﬁed GST was included as a negative control. As expected, either
Tax or STAT2 bound well to GST-p300302–661 (Fig. 6, lanes 3–4), while
no interaction was detected with GST alone (Fig. 6A, lanes 1–2).
Notably, inclusion of increasing amount of puriﬁed Tax protein in the
binding mixture dose-dependently reduced STAT2 binding to GST-
p300302–661 (Fig. 6A, lanes 5–7). This ﬁnding indicates that Tax
competes with STAT2 for binding to p300. To exclude the possibility
that Tax could interact directly with STAT2 and thereby prevent STAT2
from binding to p300, the binding mixture was subject to immuno-
precipitation with anti-Tax antibody. STAT2 was not co-precipitated
with anti-Tax antibody (Fig. 6B, upper), whereas association of p300
with Tax was detected under the same condition (Fig. 6B, lower),
indicating that Tax did not directly interact with STAT2. Together,
these data support a competition between Tax and STAT2 for p300
binding, which may account for the observed repression of STAT2 by
Tax.
Tax-mediated inhibition of JAK-STAT signaling is speciﬁc for IFN-α
In addition to STAT2, STAT1 has also been shown to interact with
CBP/p300, which plays a role in IFN-γ-induced signal transduction. To
address whether Tax might affect IFN-γ signaling via competition
with STAT1 for binding to CBP/p300, Tax-expressing plasmid was
transfected into Jurkat T cells together with pGAS-luc, a reporter
Fig. 6. (A) Tax inhibits STAT2 binding to p300. Labeled STAT2 or Tax in vitro translation
product was incubated with GST alone (lanes 1–2) or GST-p300302–661 (lanes 3–4). In
competition assay (lanes 5–7), STAT2 was incubated with GST-p300302–661 in the
presence of increasing amount of Tax. (B) Tax does not directly interact with STAT2. The
same reaction mixture was immunoprecipitated with anti-Tax antibody followed by
Western blotting with anti-Stat2 (upper) or anti-p300 (lower) antibody.
Fig. 7. Tax does not affect JAK–STAT pathway in response to IFN-γ signaling. Jurkat T
cells were transfected with GAS-luc (A) or HTLV-1 LTR-luc (B) along with pCn, pCnwtax
or pCnTaxK88A. Relative luciferase activities were determined as described for Fig. 1.
Fold induction means the luciferase activity relative to that co-transfected with the
control vector pCn. The results are from three independent triplicate experiments.
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repeats of gamma-activated sequence (GAS) element that is recog-
nized by STAT1 homodimer induced by IFN-γ. Cells were cultured in
the absence or presence of 500 IU/ml of human IFN-γ 24 h later, and
the luciferase activity was measured after an additional incubation for
24 h. As shown in Fig. 7A, the luciferase expression was signiﬁcantly
induced by treatment with IFN-γ, indicating the presence of
functional IFN-γ receptor and STAT1 in Jurkat T cells. IFN-γ-induced
luciferase expression was not signiﬁcantly affected by cotransfection
with either Tax- or TaxK88A-expressing plasmid. The luciferase
expression under the control of HTLV-I LTR, which was monitored
under the same condition, was substantially stimulated by cotransfec-
tion of Tax expression plasmid, suggesting that Tax was expressed and
its function was intact in Jurkat T cells treated with IFN-γ (Fig. 7B).
Further, expression of Taxwas conﬁrmed by immunoprecipitation and
subsequent Western blot analysis with the antibody respectively
recognizing the N and C terminus of Tax protein (data not shown).
Together with the data shown in Fig. 1, it is suggested that Tax
speciﬁcally modulates the JAK-STAT pathway in respond to IFN-α
while having no effect on the signaling via IFN-γ.
Discussion
CBP/p300 regulates a variety of transcription factors involved in
multiple signal transduction pathways, and competition between
various classes of transcription factors for limiting amounts of CBP/
p300 has been suggested as a repressionmechanism to coordinate the
transcriptional regulation of relevant genes. The transcriptional
outcomes of simultaneous stimulation of two or more signal
transduction pathways would depend on the abundance of the
transcriptional factors and their relative afﬁnities for CBP/p300.
Inhibition of Ap1-dependent gene activation by steroid receptors
and STAT1, for example, has been demonstrated to be attributable to
competitive usage of CBP/p300 (Horvai et al., 1997; Kamei et al., 1996).
Similarly, several oncogenic viruses encode viral proteins that bind to
CBP/p300 and consequently deregulate CBP/p300-mediated tran-
scription. HTLV-1-encoded Tax protein is among the best known of
these. Indeed, multiple studies have linked Tax's binding to CBP/p300with its repressive effect on the transcription directed by p53 (Ariumi
et al., 2000), p73 (Ogryzko et al., 1996), c-Myb (Dai et al., 1996), and c-
Jun (Van Orden et al., 1999), which also utilize CBP/p300 as the
coactivator. Tax deregulation of the CBP/p300-mediated transcription,
most of which are involved in apoptosis, cell cycle regulation, and
differentiation, has signiﬁcant implication in HTLV-1-associated
malignant transformation.
Here, we investigated the effect of Tax protein on IFN-α-mediated
signal pathway. Precedence for this study comes from our previous
observation showing an attenuated IFN-α-induced antiviral response
in Tax-expressing cells (Zhang et al., 2007), providing an explanation
for the clinical study revealing a signiﬁcantly lower rate of sustained
IFN-α response in HCV/HTLV co-infected individuals, relative to those
infected with HCV alone (Kishihara et al., 2001). The results presented
here indicate that Tax interferes with IFN-α-induced JAK-STAT
pathway, and the molecular basis for Tax-mediated IFN-α inhibition
appears to be the competition between Tax and STAT2 for coactivator
CBP/p300. We inferred this conclusion based on the following
observations. Firstly, Tax's abilities to activate CREB-dependent path-
way (Fig. 1A) and to bind CBP (Fig. 4A) are necessary for its repression
on ISGF3-directed transcription. Secondly, in the presence of Tax, the
formation of DNA-binding ISGF3 complex is unaffected (Fig. 2A)
nevertheless being functionally compromised in directing ISRE-driven
gene expression. Thirdly, Tax dose-dependently inhibits the binding of
STAT2 to p300 in vitro (Fig. 6A), and there is no direct interaction
between Tax and STAT2 in immunoprecipitation assay (Fig. 6B).
Finally, Tax also inhibits the transcriptional activity of GAL4-Stat2(TA)
containing the transactivation domain of STAT2 fusedwith GAL4 DNA-
binding domain (Fig. 3), and Tax repression on ISGF3 was restored by
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suggest that Tax competitively binds to CBP/p300 and disables its
function in ISGF3-directed transcription.
Tax m319, which corresponds to the previously characterized M47
Tax mutant (Smith and Greene 1990), contains two amino acid
mutations (L319R and L320S) in the carboxy-terminal domain. While
Harrod et al. (1998) identiﬁed the KID-like domain around amino acid
residues 81–95 as the major CBP-binding domain of Tax, Bex et al.
(1998) reported that M47 mutant is impaired in CBP binding, thus
explaining its inability to activate CREB pathway. A compromised
interpretation is that the KID-like domain in Tax is critical for the
recruitment of CBP/p300 but additional contact(s) might also be
required for interaction of Tax with CBP/p300. Alternatively, the
carboxy-terminal domain might play a role in maintaining the overall
structure and/or promoting the conformational change to render the
KID-like domain accessible to CBP/p300. If this is the case, the
mutations in Tax m319 might attenuate the ability of Tax to sequester
CBP/p300, thereby failing to suppress ISRE-luc expression. Actually, a
similar observation was previously reported by Ariumi et al. (2000),
who demonstrated that the mutations in Tax m319 abrogated the
ability of Tax to repress p53-directed transcription by competitive
binding to CBP. Further studies are now in progress to clarify this issue.
Repression of STAT2 by Tax is reminiscent of the scenario described
in adenovirus-encoded E1A protein, which has been demonstrated to
repress STAT2 transactivation and IFN-α-induced transcription at
least in part through competition for CBP/p300 (Bhattacharya et al.,
1996). In addition to these two viruses, viral proteins encoded by other
oncogenic viruses, such as large T antigen from SV40 (Eckner et al.,
1996) and polyomavirus (Cho et al., 2001), E6 protein from human
papillomavirus (Patel et al., 1999), and Tat protein from HIV-1 (Ott et
al., 1999), also bind to CBP/p300 and deregulate CBP/p300-mediated
cellular transcription, it is thus probable, but remains to be proven,
that an analogous anti-IFN strategy might also be employed by these
viruses. It is known that interaction of Taxwith the KIX domain of CBP/
p300 is crucial for Tax-mediated coactivator recruitment, although
additional contacts may further strengthen the interaction and
contribute to Tax's transcription function. In the case of STAT2,
previous studies have identiﬁed the CH1 domain as the binding site
(Bhattacharya et al., 1996). CH1 domain is located immediately amino-
terminal to the KIX domain. It is thus possible that steric hindrance or
conformational changes following binding of Tax to CBP/p300 might
result in the diminishment of STAT2 binding by blocking access of
STAT2 to its binding sites. Additionally, it was reported that the
transcriptional repression between Tax and p73β, c-Myb, c-Jun
pathway is reciprocal (Lemasson and Nyborg, 2001; Van Orden et
al., 1999). In a reporter assay to investigate whether STAT2 similarly
repress Tax function, however, we found that overexpression of STAT2
didn’t obviously affect Tax-stimulated HTLV-1 transcription (data not
shown), suggesting that STAT2 could not inhibit binding of Tax to CBP/
p300 and affect its ability to function as a coactivator in conjunction
with CREB transcription factor. The failure of STAT2 to displace Tax
from CBP/p300 is probably due to a higher afﬁnity of Tax than STAT2
for CBP/p300. Alternatively, KIX domainmay remain accessible for Tax
binding and STAT2 displacement after binding of STAT2 to CH1
domain. Actually, a similar observation was previously reported by
Riou et al., who demonstrated that Tax represses MyoD-dependent
transcription by inhibiting MyoD-binding to the KIX domain of p300,
but not vice versa (Riou et al., 2000). On the contrary, co-transfection
of STAT2-expressing plasmid signiﬁcantly inhibited Tax stimulation of
HIV-1 transcription (data not shown), which involves activation of NF-
κB pathway by Tax. Binding of STAT2 to CBP/p300 affects its ability to
function as a coactivator in NF-κB- but not in CREB-dependent
transcription, which may not be surprising considering that STAT2
binds to CH1 domain distinct from Tax and CREB, whereas both STAT2
and RelA of NF-κB share a common binding site (CH1) on CBP/p300.
Consistent with this observation, binding of STAT2 to p300 incompetition with RelA was demonstrated as the mechanism by
which IFN-α inhibited TNF-α stimulation of HIV gene expression via
NF-κB (Hottiger et al., 1998).
The data presented here indicate that Tax speciﬁcally deregulated
the JAK-STAT pathway in respond to IFN-α but having no effect on the
signaling via IFN-γ, suggesting that Tax did not interfere with the
recruitment of CBP by STAT1. This is probably attributable to the fact
that STAT1 interacts with the CH3 domain of CBP/p300 (Zhang et al.,
1996), a region is relatively far from the binding site of Tax (KIX
domain), and the CH3 domain may remain accessible for STAT1
binding after binding of Tax to KIX domain. Also, an alternative
explanation for the different effects of Tax on IFN-α and IFN-γ
signaling might be due to the difference in afﬁnity of STAT2 and STAT1
for CBP/p300 binding, relative to that of Tax.
The ability of Tax to inhibit ISGF3 transactivation has potential
biological implications. Like IFN-γ, IFN-α also plays a critical role in
cancer immunosurveillance and immunoediting (Dunn et al., 2005).
Impaired IFN-α signaling might therefore result in a loss of both the
normal control of proliferation and regulation of apoptosis, thereby
increasing the malignant behavior (Matin et al., 2001; Picaud et al.,
2002). Indeed, reduced IFN-α-responsiveness has been linked to
malignancy in various cancer types. For example, it was reported that
deﬁciency in ISGF3 activity, due to suppressed expression of one or
more components of ISGF3 complex, was involved in the pathogenesis
of squamous cell carcinoma of the skin (Clifford et al., 2002). Further, it
was demonstrated that stable expression of dominant negative STAT2
suppressed IFN-α-induced growth inhibitory response in highly IFN-
α-sensitive human cells (Clifford et al., 2003). It is thus conceivable
that repression of ISGF3 transactivation by Tax could contribute to the
HTLV-1-associated malignancy by conferring a growth and/or survival
advantage. Consistent with this hypothesis, it was previously reported
that HTLV-1-infected T cells evade the antiproliferative action of IFN-β
while having normal level of IFNAR1 expression and STAT phosphor-
ylation (Smith et al., 1999). Additionally, ISGF3-directed transcription
is a crucial step in transducing IFN-α-mediated antiviral response. The
data presented here suggest that Tax-mediated ISGF3 inhibitionmight
lead to a global repression of antiviral defense gene expression,
thereby rendering unhindered viral replication. In addition to
facilitating the replication of HTLV-1 itself, the antagonistic effect of
Tax on IFN might also modulate the replication of other co-existing
viral pathogens, providing a possible mechanism for the severer
clinical consequence of viral infectious disease and poorer IFN-α
responsiveness in patients co-infected with HTLV-1 (Boschi-Pinto et
al., 2000; Kishihara et al., 2001). However, one concern in interpreting
the physiological relevance of the results obtained here is that the
level of Tax expression in HTLV-1-infected patients may be lower than
that in established cell lines used here. In view that the titrating study
was not performed here, it thus cannot be ruled out that Tax-mediated
anti-IFN effect might be milder in vivo than that observed here.
While themanuscript was being prepared, Feng and Ratner reported
that HTLV-1 down-regulates IFN-α-stimulated JAK-STAT signaling by
reducing phosphorylation of tyrosine kinase 2 and STAT2, and provided
evidence suggesting that Gag or Pr may be responsible for HTLV-1-
mediated IFN-α inhibition (Feng and Ratner, 2008). Our data, however,
do not support that Tax perturbs the events involved in the formation of
DNA-binding ISGF3 complex. As shown in the result of EMSA (Fig. 2A),
IFN-α-induced ISGF3 formation inHuhwtaxwas similar to that detected
in HuhCn cells. Huhwtax constitutively expresses Tax protein at a level
comparable to that inHTLV-1-infectedMT-2 cells (Fig. 2B), andmoreover
this level of Tax expression conferred an attenuated IFN-α-induced
antiviral response in Huhwtax cells (Zhang et al., 2007). Thus, the
possibility that unaffected formation of ISRE-binding ISGF3 complex in
Huhwtaxwas due to insufﬁcient Taxexpression in these cellswas largely
lessened, if could not be ruled out completely, allowing us to infer that
Tax inhibits IFN-α signaling via a mechanism other than derailing the
events involved in the formation of DNA-binding ISGF3 complex.
312 J. Zhang et al. / Virology 379 (2008) 306–313Nonetheless, the data presented here are not contradictory to the
conclusion drawn from theRatner's study, and it is possible that different
HTLVgeneproductsmayact at different level of the JAK-STATsignaling to
counteract IFN's action. Actually, it is frequently that viruses employ
more than one strategy to evade IFN system.
In conclusion, we investigated here the effect of HTLV-1-encoded
Tax protein on IFN-α signaling pathway, and provide evidence
demonstrating that Tax negatively modulates IFN-α-induced JAK-
STAT pathway by competing with STAT2 for coactivator CBP/p300. Tax
preventing IFN-α from inducing an antiviral state and programming
cell death provides an additional mechanism for the role of Tax in
persistent viral infection and development of ATLL in HTLV-1-infected
individuals, highlighting the signiﬁcance of the anti-HTLV strategies
targeting Tax protein.
Materials and methods
Plasmids
Empty plasmid pCn, and plasmids encoding wild-type HTLV Tax
(pCnwtax) or its mutants (pCnm148 and pCnm319, K88A) have all
been described previously (Yamaoka et al; 1996; Zhang et al., 2007;
Harrod et al., 1998). The reporter vectors, pISRE-luc and pGAS-luc,
were purchased from Stratagene. For construction of pGAL4-Stat2(TA),
the cDNA of STAT2 transactivation domain (amino acids 670–851) was
ampliﬁed with primers 5′-atctgcgatcgccatgCGGGATGAAGCTTTT-
GGGTG-3′ and 5′-acctgtttaaacCTAGAAGTCAGAAGGCAT-3′, digested
with Sgf I and Pme I, and ligated into in pFN11A(BIND) Flexi vector
(Promega), which had been cut with the same enzymes immediate
downstream of GAL4 DNA-binding domain. The cDNA insert for pGEX-
p300 (amino acids 302–661) was generated by PCR using primers 5′-
ataggatccatgGGTCAACAGCCAGCCCCG-3′ and 5′-agagaattctcaAG-
CATTTGGTAGCATGTTCTG-3′, digested with BamH I and EcoR I and
ligated into BamH I/EcoR I-digested pGEX-2Z (Amersham). The
sequences of these constructs were conﬁrmed by nucleotide
sequencing.
Cells
Human hepatoma cell line Huh-7 and human cervical carcinoma
HeLa cells were purchased from the American Type Culture Collection
(ATCC) and maintained in Dulbecco's modiﬁed Eagle's medium
(DMEM, Invitrogen) supplemented with 10% fetal calf serum and
50 U/ml penicillin and streptomycin. Jurkat T-lymphocytes were
maintained in RPMI1640 medium supplement with 15% fetal calf
serum. The cell line Huhwtax, which stably expresses Tax at a level
comparable to HTLV-1-infected MT-2 cells, was established by
transfecting Huh-7 cells with pCnwtax followed by G418 selection
and limiting dilution.
Transient transfection and luciferase assay
Cells were seeded at 1×105 in 1 ml medium per well of 12-well
plates 24 h before transfection. Indicated plasmid DNAs were
transfected into cells with FuGENE6 (Roche). For each transfection,
pRL-TK (Promega) vector was cotransfected as an internal control to
normalize the transfection efﬁciency. The cells were harvested at 48 h
posttransfection, and the cell lysates were prepared for luciferase
assays with Dual-Luciferase Reporter Assay System (Promega)
according to the manufacturer’s instruction. Luciferase activities
were measured using a TD-20/20 Luminometer (Promega).
EMSA
The probe used in the EMSAwas obtained by annealing biotinylated
consensus ISRE oligonucleotides (AGGAAATAGAAACTG)2 and its com-plement. Nuclear extracts were prepared from the cells treated with or
without IFN-α using NE-PER Nuclear and Cytoplasmic Extraction
Reagent Kit (Pierce). EMSA was performed with the Lightshift Chemi-
luminescent EMSA Kit (Pierce) and the signals were detected with
streptavidin-horseradish peroxidase conjugate and chemiluminescent
substrate. For competition experiments, unlabeled double-strand oligo-
nucleotides were used in a 50-fold molar excess. For supershift
experiments, nuclear extracts were pre-incubated for 30 min with
speciﬁc antibodies before addition to the binding reaction.
GST pull-down assay
GST-p300302–661 fusion protein was induced by isopropyl-thioga-
lactopyranoside in BL21 Escherichia coli transformed with pGEX-p300,
puriﬁed by binding to glutathione-Sepharose 4B (Bulk GST Puriﬁca-
tionModule, GE Healthcare), and dialyzedwith PBS overnight. Tax and
STAT2 proteins were in vitro translated with the TNT-coupled
reticulocyte lysate systems kit (Promega) and labeled with Transcend
tRNA (Promega). GST or GST-p300302–661 was incubated with Tax or
STAT2 in binding buffer. GS4B beadswere added and incubated for 1 h.
Proteins that bound to the beads were separated by SDS/PAGE and
detected with streptavidin-horseradish peroxidase and chemilumi-
nescent substrate.
Western blot analysis
Separation of protein on sodium dodecyl sulfate-polyacrylamide
gel electrophoresis followed standard methods. After the proteins
were transferred to Hybond-P PVDV Membrane (GE Healthcare), the
membranes were blocked and then probed with monoclonal antibody
speciﬁc for HTLV-I Tax (AS-5703, Microbix Biosystems Inc.), and
signals were visualized with ECL Plus Western Blotting Detection
Reagents (GE Healthcare).
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